Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Simulating Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model.

Campos M, Capilla R, Naya F, Futami R, Coque T, Moya A, Fernandez-Lanza V, Cantón R, Sempere JM, Llorens C, Baquero F.

MBio. 2019 Jan 29;10(1). pii: e02460-18. doi: 10.1128/mBio.02460-18.

2.

A schizophrenia associated CMYA5 allele displays differential binding with desmin.

Hsiung A, Naya FJ, Chen X, Shiang R.

J Psychiatr Res. 2019 Jan 10;111:8-15. doi: 10.1016/j.jpsychires.2019.01.007. [Epub ahead of print]

PMID:
30658136
3.

Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling.

Farrell E, Armstrong AE, Grimes AC, Naya FJ, de Lange WJ, Ralphe JC.

Front Physiol. 2018 Oct 25;9:1442. doi: 10.3389/fphys.2018.01442. eCollection 2018.

4.

A Hearty Dose of Noncoding RNAs: The Imprinted DLK1-DIO3 Locus in Cardiac Development and Disease.

Dill TL, Naya FJ.

J Cardiovasc Dev Dis. 2018 Jul 10;5(3). pii: E37. doi: 10.3390/jcdd5030037. Review.

5.

The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart.

Medrano JL, Naya FJ.

J Biol Chem. 2017 Dec 22;292(51):20975-20988. doi: 10.1074/jbc.M117.806422. Epub 2017 Oct 20.

6.

Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors.

Desjardins CA, Naya FJ.

J Biol Chem. 2017 Jun 23;292(25):10613-10629. doi: 10.1074/jbc.M117.776153. Epub 2017 May 4.

7.

(MYO)SLIDing Our Way Into the Vascular Pool of Long Noncoding RNAs.

Naya FJ, Wang DZ.

Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2033-4. doi: 10.1161/ATVBAHA.116.308173. No abstract available.

8.
9.

miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy.

Clark AL, Maruyama S, Sano S, Accorsi A, Girgenrath M, Walsh K, Naya FJ.

PLoS One. 2016 Mar 21;11(3):e0151515. doi: 10.1371/journal.pone.0151515. eCollection 2016.

10.

MEF2D deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro.

Estrella NL, Clark AL, Desjardins CA, Nocco SE, Naya FJ.

J Biol Chem. 2015 Oct 2;290(40):24367-80. doi: 10.1074/jbc.M115.666461. Epub 2015 Aug 20.

11.
12.

Correction: EGR1 functions as a potent repressor of MEF2 transcriptional activity.

Feng Y, Desjardins CA, Cooper O, Kontor A, Nocco SE, Naya FJ.

PLoS One. 2015 Jun 24;10(6):e0131619. doi: 10.1371/journal.pone.0131619. eCollection 2015. No abstract available.

13.

EGR1 Functions as a Potent Repressor of MEF2 Transcriptional Activity.

Feng Y, Desjardins CA, Cooper O, Kontor A, Nocco SE, Naya FJ.

PLoS One. 2015 May 26;10(5):e0127641. doi: 10.1371/journal.pone.0127641. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131619.

14.

MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation.

Estrella NL, Desjardins CA, Nocco SE, Clark AL, Maksimenko Y, Naya FJ.

J Biol Chem. 2015 Jan 9;290(2):1256-68. doi: 10.1074/jbc.M114.589838. Epub 2014 Nov 21.

15.

Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Estrella NL, Naya FJ.

Cell Mol Life Sci. 2014 May;71(9):1641-56. doi: 10.1007/s00018-013-1512-0. Epub 2013 Nov 12. Review.

16.

MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration.

Snyder CM, Rice AL, Estrella NL, Held A, Kandarian SC, Naya FJ.

Development. 2013 Jan 1;140(1):31-42. doi: 10.1242/dev.081851. Epub 2012 Nov 15.

17.

The Mef2A transcription factor coordinately regulates a costamere gene program in cardiac muscle.

Ewen EP, Snyder CM, Wilson M, Desjardins D, Naya FJ.

J Biol Chem. 2011 Aug 26;286(34):29644-53. doi: 10.1074/jbc.M111.268094. Epub 2011 Jul 1.

18.

Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration.

Kielbasa OM, Reynolds JG, Wu CL, Snyder CM, Cho MY, Weiler H, Kandarian S, Naya FJ.

FASEB J. 2011 Jul;25(7):2276-86. doi: 10.1096/fj.10-169219. Epub 2011 Mar 22.

19.

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Konno T, Chen D, Wang L, Wakimoto H, Teekakirikul P, Nayor M, Kawana M, Eminaga S, Gorham JM, Pandya K, Smithies O, Naya FJ, Olson EN, Seidman JG, Seidman CE.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18097-102. doi: 10.1073/pnas.1012826107. Epub 2010 Oct 5.

20.

Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.

McCalmon SA, Desjardins DM, Ahmad S, Davidoff KS, Snyder CM, Sato K, Ohashi K, Kielbasa OM, Mathew M, Ewen EP, Walsh K, Gavras H, Naya FJ.

Circ Res. 2010 Mar 19;106(5):952-60. doi: 10.1161/CIRCRESAHA.109.209007. Epub 2010 Jan 21.

21.

A three-layered model of nursing based on hospital observation data.

Ohboshi N, Tanaka T, Kuwahara N, Ozaku HI, Naya F, Kogure K.

Methods Inf Med. 2009;48(6):574-81. doi: 10.3414/ME9245. Epub 2009 Nov 5.

PMID:
19893858
22.

Complete loss of murine Xin results in a mild cardiac phenotype with altered distribution of intercalated discs.

Otten J, van der Ven PF, Vakeel P, Eulitz S, Kirfel G, Brandau O, Boesl M, Schrickel JW, Linhart M, Hayess K, Naya FJ, Milting H, Meyer R, Fürst DO.

Cardiovasc Res. 2010 Mar 1;85(4):739-50. doi: 10.1093/cvr/cvp345. Epub 2009 Oct 19.

PMID:
19843512
23.

Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy.

Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ.

J Biol Chem. 2008 Mar 28;283(13):8070-4. doi: 10.1074/jbc.C700221200. Epub 2008 Feb 5.

24.

Identification and mapping of protein kinase A binding sites in the costameric protein myospryn.

Reynolds JG, McCalmon SA, Tomczyk T, Naya FJ.

Biochim Biophys Acta. 2007 Jun;1773(6):891-902. Epub 2007 Apr 14.

25.

Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy.

Parsons SA, Millay DP, Sargent MA, Naya FJ, McNally EM, Sweeney HL, Molkentin JD.

J Biol Chem. 2007 Mar 30;282(13):10068-78. Epub 2007 Feb 7.

26.

The proposal of measurement of RNs at acute care setting cognitive process when they make cognitive error.

Hashimoto M, Kuwahara N, Naya F, Noma H, Kogure K, Osuga M.

Stud Health Technol Inform. 2006;122:455-7.

PMID:
17102299
27.

Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related alpha-actinin-interacting protein.

Huang HT, Brand OM, Mathew M, Ignatiou C, Ewen EP, McCalmon SA, Naya FJ.

J Biol Chem. 2006 Dec 22;281(51):39370-9. Epub 2006 Oct 17.

28.

Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, alpha-actinin-interacting, costamere-localized protein.

Durham JT, Brand OM, Arnold M, Reynolds JG, Muthukumar L, Weiler H, Richardson JA, Naya FJ.

J Biol Chem. 2006 Mar 10;281(10):6841-9. Epub 2006 Jan 3.

29.

Improving visualization skills in engineering education.

Contero M, Naya F, Company P, Saorín JL, Conesa J.

IEEE Comput Graph Appl. 2005 Sep-Oct;25(5):24-31. No abstract available.

PMID:
16209167
30.

Calcineurin activation influences muscle phenotype in a muscle-specific fashion.

Talmadge RJ, Otis JS, Rittler MR, Garcia ND, Spencer SR, Lees SJ, Naya FJ.

BMC Cell Biol. 2004 Jul 28;5:28.

31.

Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.

Naya FJ, Black BL, Wu H, Bassel-Duby R, Richardson JA, Hill JA, Olson EN.

Nat Med. 2002 Nov;8(11):1303-9. Epub 2002 Oct 15.

PMID:
12379849
32.

Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.

Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, Williams RS.

EMBO J. 2001 Nov 15;20(22):6414-23.

33.

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN.

J Clin Invest. 2000 May;105(10):1395-406.

34.

Neuronal basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule cell differentiation in the hippocampus.

Schwab MH, Bartholomae A, Heimrich B, Feldmeyer D, Druffel-Augustin S, Goebbels S, Naya FJ, Zhao S, Frotscher M, Tsai MJ, Nave KA.

J Neurosci. 2000 May 15;20(10):3714-24. Erratum in: J Neurosci 2000 Nov 1;20(21):8227.

35.

MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.

Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, Simard AR, Michel RN, Bassel-Duby R, Olson EN, Williams RS.

EMBO J. 2000 May 2;19(9):1963-73.

36.

Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo.

Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN.

J Biol Chem. 2000 Feb 18;275(7):4545-8.

37.

Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy.

Liu M, Pleasure SJ, Collins AE, Noebels JL, Naya FJ, Tsai MJ, Lowenstein DH.

Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):865-70. Erratum in: Proc Natl Acad Sci U S A 2000 May 9;97(10):5679.

38.
39.

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.

Musarò A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N.

Nature. 1999 Aug 5;400(6744):581-5.

PMID:
10448862
40.

Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene.

Naya FJ, Wu C, Richardson JA, Overbeek P, Olson EN.

Development. 1999 May;126(10):2045-52.

42.

Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice.

Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ.

Genes Dev. 1997 Sep 15;11(18):2323-34.

43.

Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31-35.

Owerbach D, Naya FJ, Tsai MJ, Allander SV, Powell DR, Gabbay KH.

Diabetes. 1997 Jun;46(6):1069-74.

PMID:
9166681
44.

The basic helix-loop-helix transcription factor BETA2/NeuroD is expressed in mammalian enteroendocrine cells and activates secretin gene expression.

Mutoh H, Fung BP, Naya FJ, Tsai MJ, Nishitani J, Leiter AB.

Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3560-4.

45.

BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes.

Peyton M, Stellrecht CM, Naya FJ, Huang HP, Samora PJ, Tsai MJ.

Mol Cell Biol. 1996 Feb;16(2):626-33.

46.
47.
49.

Electrophoretic studies on sera in animals immunized with ascites tumors of albino rat. II.

AIZAWA M, NAYA F, SUYAMA T, IRIE M, KAJI S.

Gan. 1955 Sep;46(2-3):145-8. No abstract available.

PMID:
13262304
50.

Studies on the changes of antigenicity of ascites tumor and normal tissue of rat treated with several physical and chemical methods.

HAYASHISHITA T, NAOE K, KAJI T, NAYA F, OGASAWARA K.

Gan. 1954 Sep;45(2-3):361-4. No abstract available.

PMID:
13220901

Supplemental Content

Support Center